Both genes appear to exhibit tissue-specific effects, with upregulation of EPHB2 reported to be associated with poor breast cancer survival31 and elevated expression of PDLIM1 reported to promote metastatic processes in breast and glioma32, 33. Here, EPHB2 is linked to breast cancer.